Charles S. Tressler, MD
Dr. Tressler received his undergraduate degree from the University of Pittsburgh, School of Pharmacy (BS in Pharmacy, summa cum laude) and my MD from Hahnemann Medical College and Hospital of Philadelphia (now Drexel University) with academic distinction in pharmacology. He received the Army Commendation Medal and Meritorious Service Medal while on active duty. He was also selected to “Best Doctors in America” 1996 and 1998. Dr. Tressler received the American Academy of Ophthalmology Honor Award while in private practice and teaching residents. He was awarded the J. Edward Berk Award for Attending Staff Contributing Most to House Staff Education, Sinai Hospital of Detroit.
He joined Pharmacia and Upjohn in 1999 as a medical director in R&D. He was responsible for ophthalmology projects which covered retina, glaucoma and ocular devices (glaucoma implants, intra-ocular lenses, and visco-elastics). In addition, he was the medical representative for due diligence and in-licensing opportunities. He was also Medical director at Merck before returning to Pfizer in 2006. At Merck, he participated in the submission of dorzolamide ophthalmic solution to the FDA for approval in the pediatric population. Since returning to Pfizer, he has been working in Subspecialty Care, Ophthalmology, CDMA on Xalatan Pediatric approval, Xalacom support WW, Macugen, early assets in glaucoma and retinal diseases, Chair of the Publication for ophthalmology Ocular safety Council for Ophthalmology and providing specific product support for compounds suspected of manifesting ocular conditions. He is now Safety Surveillance Risk Management Lead for Neuroscience and Pain which he assumed in October 2010.
Dr. Tressler presently volunteers at Hill Health Center, Yale University, New Haven, CT (resident education, ophthalmology) and the Ophthalmology Clinic at the United States Military Academy, West Point, NY where he volunteers as an ophthalmologist for a glaucoma clinic.